Burden of disease
Burden of disease analysis assesses the health impact on a population of different diseases, conditions, injuries and risk factors. The Australian Burden of Disease Study 2015 (AIHW 2019a) used information from a range of sources to quantify the fatal and non-fatal effects of these diseases.
Type 2 diabetes was the 12th largest contributor to Australia’s disease burden in 2015, accounting for 2.2% of total burden of disease. The burden from type 2 diabetes increased slightly from 1.8% in 2003 to 2.2% in 2011, and remained unchanged between 2011 and 2015. Type 1 diabetes contributed to 0.3% of Australia’s disease burden in 2015—unchanged from both 2003 and 2011.
In 2015, 4.7% of the total burden of disease was attributed to high blood plasma glucose levels (which includes diabetes and pre-diabetes).
Expenditure
In 2015–16, an estimated 2.3% ($2.7 billion) of total disease expenditure in the Australian health system was attributed to diabetes (AIHW 2019b). Further information is available from the Disease expenditure in Australia report.
References
AIHW 2019a. Australian Burden of Disease Study: impact and causes of illness and death in Australia 2015. Australian Burden of Disease series no. 19. Cat. no. BOD 22. Canberra: AIHW. Viewed 24 March 2020.
AIHW 2019b. Disease expenditure in Australia. Cat. no. HWE 76. Canberra: AIHW. Viewed 24 March 2020.